![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 405/06 | (2006.01) |
A61K 31/4025 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2796457 |
(13) | Kind of document | T |
(96) | European patent application number | 14164650.5 |
Date of filing the European patent application | 2010-11-24 | |
(97) | Date of publication of the European application | 2014-10-29 |
(45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
(46) | Date of publication of the claims translation | 2016-09-12 |
(30) | Number | Date | Country code |
264748 P | 2009-11-27 | US |
(72) |
Liu, Hanlan, US
Willis, Chris, US
Bhardwaj, Renu, US
Copeland, Diane, P., US
Harianawala, Abizer, US
Skell, Jeffrey, US
Marshall, John, US
Kochling, Jianmei, US
Palace, Gerard, US
Peterschmitt, Judith, US
Siegel, Craig, US
Cheng, Seng, US
|
(73) |
Genzyme Corporation,
500 Kendall Street, Cambridge, MA 02142,
US
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Genz 112638, skirtas Gošė arba Fabri ligos gydymui kombinuota terapija |
GENZ 112638 FOR TREATING GAUCHER OR FABRY DISEASE IN COMBINATION THERAPY |
Payment date | Validity (years) | Amount | |
2024-10-24 | 15 | 289.00 EUR |
2025-11-24 |